Patents by Inventor Sung-Gil CHI

Sung-Gil CHI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anticancer prodrug for overcoming drug resistance
    Patent number: 11241501
    Abstract: Disclosed is an anticancer prodrug that disturbs energy metabolism in cancer cells to overcome drug resistance. The anticancer prodrug has a structure including a pyruvate dehydrogenase kinase (PDK) inhibitor moiety, a mitochondrial targeting group, and an anthracycline moiety reversibly connected to the PDK inhibitor moiety and the targeting group.
    Type: Grant
    Filed: August 22, 2019
    Date of Patent: February 8, 2022
    Assignee: Korea University Research and Business Foundation
    Inventors: Jong Seung Kim, Amit Sharma, Min Goo Lee, Miae Won, Jin Yong Lee, Sung-Gil Chi, Jonathan L. Sessler
  • ANTICANCER PRODRUG FOR OVERCOMING DRUG RESISTANCE
    Publication number: 20200129626
    Abstract: Disclosed is an anticancer prodrug that disturbs energy metabolism in cancer cells to overcome drug resistance. The anticancer prodrug has a structure including a pyruvate dehydrogenase kinase (PDK) inhibitor moiety, a mitochondrial targeting group, and an anthracycline moiety reversibly connected to the PDK inhibitor moiety and the targeting group.
    Type: Application
    Filed: August 22, 2019
    Publication date: April 30, 2020
    Applicant: Korea University Research and Business Foundation
    Inventors: Jong Seung KIM, Amit SHARMA, Min Goo LEE, Miae WON, Jin Yong LEE, Sung-Gil CHI, Jonathan L. Sessler